1. Home
  2. LGND vs CSGS Comparison

LGND vs CSGS Comparison

Compare LGND & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CSGS
  • Stock Information
  • Founded
  • LGND 1987
  • CSGS 1994
  • Country
  • LGND United States
  • CSGS United States
  • Employees
  • LGND N/A
  • CSGS N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CSGS EDP Services
  • Sector
  • LGND Health Care
  • CSGS Technology
  • Exchange
  • LGND Nasdaq
  • CSGS Nasdaq
  • Market Cap
  • LGND 2.0B
  • CSGS 1.9B
  • IPO Year
  • LGND 1992
  • CSGS 1996
  • Fundamental
  • Price
  • LGND $124.30
  • CSGS $61.55
  • Analyst Decision
  • LGND Strong Buy
  • CSGS Buy
  • Analyst Count
  • LGND 8
  • CSGS 8
  • Target Price
  • LGND $144.71
  • CSGS $68.29
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CSGS 194.3K
  • Earning Date
  • LGND 08-05-2025
  • CSGS 08-06-2025
  • Dividend Yield
  • LGND N/A
  • CSGS 2.08%
  • EPS Growth
  • LGND N/A
  • CSGS 33.32
  • EPS
  • LGND N/A
  • CSGS 2.92
  • Revenue
  • LGND $181,488,000.00
  • CSGS $1,201,566,000.00
  • Revenue This Year
  • LGND $18.41
  • CSGS $4.49
  • Revenue Next Year
  • LGND $18.87
  • CSGS $3.92
  • P/E Ratio
  • LGND N/A
  • CSGS $21.09
  • Revenue Growth
  • LGND 53.40
  • CSGS 3.08
  • 52 Week Low
  • LGND $81.74
  • CSGS $42.46
  • 52 Week High
  • LGND $129.90
  • CSGS $67.60
  • Technical
  • Relative Strength Index (RSI)
  • LGND 64.68
  • CSGS 42.13
  • Support Level
  • LGND $120.68
  • CSGS $61.68
  • Resistance Level
  • LGND $127.07
  • CSGS $66.99
  • Average True Range (ATR)
  • LGND 3.76
  • CSGS 1.33
  • MACD
  • LGND 0.86
  • CSGS -0.32
  • Stochastic Oscillator
  • LGND 81.95
  • CSGS 16.38

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.

Share on Social Networks: